Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. - Wikidata - awgldk - TriplyDB

Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.

Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.

http://www.wikidata.org/entity/Q33684855

about

The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension Recent advances involving the renin-angiotensin system Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes.Angiotensin II-induced mitochondrial Nox4 is a major endogenous source of oxidative stress in kidney tubular cells ACE2 and diabetes: ACE of ACEs?Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.PI3K/AKT signaling pathway plays a role in enhancement of eNOS activity by recombinant human angiotensin converting enzyme 2 in human umbilical vein endothelial cells.ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure ACE and ACE2 in kidney disease Association of polymorphisms of angiotensin I converting enzyme 2 with retinopathy in type 2 diabetes mellitus among Chinese individuals Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.Angiotensin-converting enzyme 2: the first decade.Loss of prolyl carboxypeptidase in two-kidney, one-clip goldblatt hypertensive mice Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2 Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.Plasma and Kidney Angiotensin Peptides: Importance of the Aminopeptidase A/Angiotensin III Axis.Chymase mediates angiotensin-(1-12) metabolism in normal human hearts.Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice.Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?ACE2 alterations in kidney disease.Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis.Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways.Regulation of urinary ACE2 in diabetic mice Angiotensin II protects cortical neurons against oxygen-glucose deprivation-induced injury in vitro.Angiotensin-converting enzyme 2 as a therapeutic target for heart failure ACE2 deficiency increases NADPH-mediated oxidative stress in the kidney.Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro A Fluorometric Method of Measuring Carboxypeptidase Activities for Angiotensin II and Apelin-13 Novel neurohormonal insights with therapeutic potential in chronic heart failure.ACE2: more of Ang-(1-7) or less Ang II?Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy.Role of ACE2 in diastolic and systolic heart failure.

P2860

Q24633556-2AC528FF-A96D-4940-9929-AA2778AF212D Q28541744-3A0237CF-A002-4C32-8478-C6100E968A21 Q28569684-9018C016-6B8B-49D5-8CC2-61BE1499EC94 Q33795353-DA1EF97A-4F07-4E23-8C48-0B07E5063941 Q34260674-3D886BAB-C8FE-48AA-AEFF-162F39543D09 Q34282114-4EA62468-1AB0-4B25-AB71-68CF9941BD94 Q34341622-25BAECB9-BC86-4D13-BFDC-032AEF2364F3 Q34355126-8784DF34-C187-49C7-8174-0D4E98FA7CD3 Q34580630-7FF0E74B-1ED3-4245-BEE0-D6A06F4A2326 Q34733168-84DF7401-7E75-4FFE-A97E-ED150B1A6491 Q34784864-DB290994-702D-439F-8C45-B6E620CDFCA9 Q34866649-0DA20D05-AEB4-472C-ACA1-C346BCA39DD5 Q34892110-7BA2085C-9B2B-413C-AB8D-BC8C4340F9E3 Q35050821-DE718505-CA70-4B86-93F5-54385A8DA0BC Q35088751-C68B1B35-C118-4DE7-BDE3-B6A3736107A8 Q35152116-11A26C89-AC3A-4E43-903A-3B15A3EA774C Q35550937-FE37A947-6370-4843-9388-4E35F03A967B Q35565620-6A24FF0E-7AE6-4CCD-95DC-75F9DC95F363 Q35924552-0BF646C3-F11B-4EDB-AB3B-C6399E10BEAA Q36087047-268C7C24-5715-4CAD-B3AF-887B3AB850E3 Q36185540-47B1A1DD-4524-48AE-BE24-0FE42EBADFC9 Q36591728-BDBFDD62-C9AF-4CDC-BA88-61F3A5AA223C Q36707557-E7FC1AC5-8528-4FF2-B107-C81699283A15 Q36853840-93793871-EDA4-4DD1-B05A-BA66DE4E1951 Q36923658-85C26524-E0C4-4A31-BEED-A870D18D5F0F Q37081415-01F59FD8-5EDD-456A-8502-D38C9AD1A996 Q37162741-EBD279D0-EA96-412E-948B-AE0E6CEF1EA3 Q37262837-A6773436-0AD3-438E-9EFA-76C68BD64A9A Q37314369-F1473095-EFE8-4B1C-A201-C440DDF33B66 Q37454928-53C41CDB-63D6-4963-B7E6-648B73085C06 Q37476622-F8CE63E8-6BBF-4F7C-8784-B57A687B92C7 Q37565012-FCA69301-E819-41C9-B781-4FCC56C0FAEA Q37620934-1F1B55B4-AF89-42B1-8253-D8D412E48571 Q37727905-48EF3913-D948-4850-9177-560A7E57EC4C Q37731227-F5021884-3857-4D82-AA6D-E8A1E36C0DBD Q37738188-3ADE3BB0-03E0-4EC1-9389-E07131D74642 Q37749836-A3B80C14-2E31-4F84-A5C0-FDE204F40706 Q37806553-00796970-7751-40FA-A71B-6556947EE024 Q37879608-EF961984-D909-467A-81B6-78FD178ED068 Q37884450-0BB6802F-362B-4DBA-AAA5-D08912B5AA96

P2860

Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.

http://www.wikidata.org/entity/Q33684855

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Targeting the degradation of a ...... sin II-dependent hypertension.

@ast

Targeting the degradation of a ...... sin II-dependent hypertension.

@en

type

label

Targeting the degradation of a ...... sin II-dependent hypertension.

@ast

Targeting the degradation of a ...... sin II-dependent hypertension.

@en

prefLabel

Targeting the degradation of a ...... sin II-dependent hypertension.

@ast

Targeting the degradation of a ...... sin II-dependent hypertension.

@en

P1433

Q33684855-EF53A4C7-800A-4536-A901-F233229C4CC6

P1476

Q33684855-4F2243AF-CB69-4664-BC88-8702E3426476

P2093

Q33684855-048A10C3-3FE1-497C-A377-98D313458278

Q33684855-29DDBD1F-A672-4A1C-804E-5F04329118FB

Q33684855-6F09054B-C5BC-43CD-BB80-4A595E804DFD

Q33684855-7AB0B0D9-2155-4A0A-A802-0283275D2C64

Q33684855-AA0880A8-3062-402B-BCED-63ACD16AE9F5

Q33684855-AA4FA667-AE22-4B7A-A51A-3177E713A58C

Q33684855-CC3CB1C1-5A70-46AF-9767-BD507396977E

Q33684855-D27CE966-A15D-4430-B7C3-510FA803DA92

Q33684855-D2A98911-1514-4EA9-98B4-1B7C95EBA1A3

Q33684855-F30992D3-150B-4695-93D3-C04220CC75A5

P2860

Q33684855-194996BA-FA5C-42BF-8C52-9D56D3F19376

Q33684855-1B5685D5-53A0-4F55-B770-5E395A1E7767

Q33684855-27378D93-B58A-4E37-B20A-C91D5C2A0AFB

Q33684855-36C193E8-A8B0-4A57-B09B-5FC9575EF7AD

Q33684855-44B1F287-5FFC-4564-817C-D3BB947B5FA3

Q33684855-48DD4EA2-9AEB-4F86-8288-96B86944F00F

Q33684855-4B5C6D01-3FA1-4062-BB98-85D7E7E96762

Q33684855-5A66C2D2-8180-476B-A45D-188B6168AB9A

Q33684855-60C8523F-1A0C-4225-8AFA-B234582290D5

Q33684855-61B50504-CF30-4875-9B4B-864F93073192

P304

Q33684855-675AE6B9-E278-4E7D-8BB3-8BA9CAD2A449

P31

Q33684855-C40A9B23-0D8D-48EB-B306-85BD62016557

P356

Q33684855-2533E828-0348-4B6F-AE57-1C40CA396F78

P407

Q33684855-7BE4AF39-3F21-46E4-8B7B-D659E2ED7D2C

P433

Q33684855-2F4CE34C-3411-4D6B-9C8D-842EE5EB95EF

P478

Q33684855-E318AC99-A38D-4AD6-8114-E4C29C5974BB

P50

Q33684855-EC1C11C2-F285-45EA-A17C-D3C09A875C56

P577

Q33684855-44E303EA-8D9F-4C4B-A7CF-555666828CE1

P5875

Q33684855-C454D7B7-0AE5-42E9-9F68-91C0308E5008

P698

Q33684855-358341A1-C903-40C7-9332-90D9BA2E8632

P932

Q33684855-9944889D-D64F-4C91-B8DA-6E7CDD7B9678

P356

HYPERTENSIONAHA.109.138420

P1433

P1476

Targeting the degradation of a ...... sin II-dependent hypertension.

@en

P2093

Carlos M Ferrario

http://www.w3.org/2001/XMLSchema#string

Clara Barrios

http://www.w3.org/2001/XMLSchema#string

Daniel Batlle

http://www.w3.org/2001/XMLSchema#string

Eva Rodriguez

http://www.w3.org/2001/XMLSchema#string

Francisco R González-Pacheco

http://www.w3.org/2001/XMLSchema#string

Hans Loibner

http://www.w3.org/2001/XMLSchema#string

Jan Wysocki

http://www.w3.org/2001/XMLSchema#string

K Bridget Brosnihan

http://www.w3.org/2001/XMLSchema#string

Karla Evora

http://www.w3.org/2001/XMLSchema#string

Manfred Schuster

http://www.w3.org/2001/XMLSchema#string

P2860

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

Angiotensin-converting enzyme 2 is an essential regulator of heart function

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.

Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury

The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.

P304

90-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.109.138420

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Josef M Penninger

P577

2009-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40042087

http://www.w3.org/2001/XMLSchema#string

P698

19948988

http://www.w3.org/2001/XMLSchema#string

P932

2827767

http://www.w3.org/2001/XMLSchema#string